Aptorum Group Files Latest S-4 Amendment for DiamiR Reverse Merger, Details Shareholder Vote on Dilutive Proposals
APM sits 30% above its 52-week low of $0.65.
Summary
Aptorum Group filed its latest S-4 amendment, detailing the upcoming shareholder vote on a reverse merger with DiamiR Biosciences, which includes a reverse stock split and significant dilution for current shareholders, as the company seeks to address its going concern status and maintain its Nasdaq listing.
Key Events · M&A and Partnerships · APM
-
Reverse Merger Update
This Pre-Effective Amendment No. 4 to the S-4 filing details the proposed reverse merger with DiamiR Biosciences, where DiamiR stockholders will own approximately 70% of the combined company, and existing Aptorum shareholders 30%.
-
Shareholder Vote Scheduled
A Special Meeting on June 9, 2026, will address proposals including a reverse stock split (at a ratio between 1:2 and 1:10), domestication to Delaware, issuance of shares for the merger, and a new 4.5 million share incentive plan.
-
Guaranteed Approval
CEO Ian Huen, holding 86.71% of Aptorum's total voting power, has signed an agreement to vote in favor of all proposals, ensuring their approval without the need for other shareholder votes.
-
Going Concern & Nasdaq Compliance
The company's auditor has expressed substantial doubt about its ability to continue as a going concern, and the proposed reverse stock split is intended to help meet Nasdaq's minimum bid price requirement for continued listing.
Analysis · APM · Industrial Applications And Services
This filing provides the latest comprehensive details for Aptorum Group's proposed reverse merger with DiamiR Biosciences, including critical shareholder proposals for a reverse stock split, domestication to Delaware, and the issuance of shares that will result in existing Aptorum shareholders owning only 30% of the combined entity. The company continues to operate under a going concern warning, making this merger a crucial, albeit highly dilutive, path for its survival and continued Nasdaq listing. The CEO's controlling vote ensures all proposals will pass.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 52.4% of the 208 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.91%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, APM was trading at $0.85 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $6.9M. The 52-week trading range was $0.65 to $4.47. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.